Professor Nigel McMillan at Griffith University has discovered that the experimental drug Alisertib has successfully rid mice of cervix, head, and neck cancer caused by the papillomavirus.

Professor Nigel McMillan, who in cooperation with Professor Brian Gabrielli of the University of Queensland, has expressed their excitement for this breakthrough due to the potential application it has in human trials.

"For the first time in a long time the mice are completely cured of cancer we gave them," he said.

While a treatment for cervical cancer is already available, many other cancer treatments do massive amounts of damage to the body, such as chemotherapy.

"A lot of our cancer therapies these days are very non-specific like chemotherapy and radiation so we're trying to get something better." He continued to say "The only treatment at the moment is radiation, chemotherapy or full hysterectomy and a lot of people don't want to go through all that surgery,"

When it comes to certain types of cancers (breast, cervix, prostate etc.), sometimes very invasive measures to completely remove the area is the only way to treat the condition. The idea of having a non-invasive alternative that can help treat people without needing operation would be a big improvement.

Alisertib is already available in the U.S. where trials have been used to treat against blood cancers and solid tumours. This is good news since they hurdles towards human use have already been passed and should be available for human use very soon.

For sufferers of cancers that threaten to claim a portion of their body, this is definitely a drug to keep an eye out for.